Hepatitis B vaccine - Shanghai Fudan Haitai Biotechnology
Alternative Names: HBsAg-HBIG complex; Hepatitis B immune globulin-hepatitis B vaccine recombinant complex; Hepatitis B vaccine/hepatitis B immune globulin; Yeast-derived immunogenic complex; YICLatest Information Update: 17 Dec 2021
At a glance
- Originator Fudan University
- Developer Fudan University; Shanghai Haitai Pharmaceutical Biotechnology
- Class Hepatitis B vaccines; Immunoglobulins; Synthetic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Hepatitis B
Most Recent Events
- 05 Sep 2018 Discontinued - Phase-III for Hepatitis B in China (IM) (Shanghai Fudan Haitai Biotechnology website, September 2018)